Capula Management LTD Bio Techne Corp Transaction History

Capula Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$71.62 - $86.62 $540,301 - $653,461	-7,544 Reduced 67.51%	3,630 $269,000
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $661,816 - $2.89 Million	8,204 Added 276.23%	11,174 $926,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $839,143 - $1.16 Million	2,970 New	2,970 $843,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $372,356 - $451,042	-837 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $324,211 - $376,867	837 New	837 $377,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.